Cargando…
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections
Infections caused by Gram-positive pathogens remain a major public health burden and are associated with high morbidity and mortality. Increasing rates of infection with Gram-positive bacteria and the emergence of resistance to commonly used antibiotics have led to the need for novel antibiotics. Da...
Autores principales: | Gonzalez-Ruiz, Armando, Seaton, R Andrew, Hamed, Kamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846043/ https://www.ncbi.nlm.nih.gov/pubmed/27143941 http://dx.doi.org/10.2147/IDR.S99046 |
Ejemplares similares
-
Clinical Experience with Daptomycin for the Treatment of Gram-positive Infections in Children and Adolescents
por: Syriopoulou, Vassiliki, et al.
Publicado: (2016) -
Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry
por: Gonzalez-Ruiz, Armando, et al.
Publicado: (2015) -
Daptomycin for the Treatment of Gram-Positive Periprosthetic Hip Infections: Can Daptomycin Prevent the Implant Removal?
por: Oe, Kenichi, et al.
Publicado: (2021) -
Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin
por: White, Beth, et al.
Publicado: (2011) -
Daptomycin for the treatment of major gram-positive infections after cardiac surgery
por: Kornberger, A., et al.
Publicado: (2016)